Cargando…
Proactive versus Rank-Down Topical Corticosteroid Therapy for Maintenance of Remission in Pediatric Atopic Dermatitis: A Randomized, Open-Label, Active-Controlled, Parallel-Group Study (Anticipate Study)
Topical corticosteroids are used as first-line treatment for atopic dermatitis (AD). Regarding the maintenance of remission achieved by topical corticosteroids, no previous studies have compared proactive therapy with rank-down therapy. We compared their efficacy and safety in Japanese children with...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658234/ https://www.ncbi.nlm.nih.gov/pubmed/36362704 http://dx.doi.org/10.3390/jcm11216477 |
_version_ | 1784829900064030720 |
---|---|
author | Kamiya, Koji Saeki, Hidehisa Tokura, Yoshiki Yoshihara, Shigemi Sugai, Junichi Ohtsuki, Mamitaro |
author_facet | Kamiya, Koji Saeki, Hidehisa Tokura, Yoshiki Yoshihara, Shigemi Sugai, Junichi Ohtsuki, Mamitaro |
author_sort | Kamiya, Koji |
collection | PubMed |
description | Topical corticosteroids are used as first-line treatment for atopic dermatitis (AD). Regarding the maintenance of remission achieved by topical corticosteroids, no previous studies have compared proactive therapy with rank-down therapy. We compared their efficacy and safety in Japanese children with moderate to severe AD. Patients who had achieved remission with a very strong topical corticosteroid were randomized to 4-week maintenance treatment with either intermittent use of the same drug (proactive therapy) or daily use of a strong topical corticosteroid for 1 week followed by daily use of a medium-potency topical corticosteroid for 3 weeks (rank-down therapy); 49 patients were randomized (proactive therapy, n = 24; rank-down therapy, n = 25). During maintenance treatment, the relapse rate was 8.33% in the proactive therapy group and 20.0% in the rank-down therapy group (p = 0.0859). The mean (±standard deviation) itching score on a numerical rating scale in the rank-down therapy group increased significantly from 2.5 ± 1.9 to 3.6 ± 2.6 (p = 0.0438). Adverse events occurred in 2 patients receiving proactive therapy and 3 patients receiving rank-down therapy. Proactive therapy appears to be as safe as rank-down therapy and may be more effective for itch in pediatric AD in remission. |
format | Online Article Text |
id | pubmed-9658234 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-96582342022-11-15 Proactive versus Rank-Down Topical Corticosteroid Therapy for Maintenance of Remission in Pediatric Atopic Dermatitis: A Randomized, Open-Label, Active-Controlled, Parallel-Group Study (Anticipate Study) Kamiya, Koji Saeki, Hidehisa Tokura, Yoshiki Yoshihara, Shigemi Sugai, Junichi Ohtsuki, Mamitaro J Clin Med Article Topical corticosteroids are used as first-line treatment for atopic dermatitis (AD). Regarding the maintenance of remission achieved by topical corticosteroids, no previous studies have compared proactive therapy with rank-down therapy. We compared their efficacy and safety in Japanese children with moderate to severe AD. Patients who had achieved remission with a very strong topical corticosteroid were randomized to 4-week maintenance treatment with either intermittent use of the same drug (proactive therapy) or daily use of a strong topical corticosteroid for 1 week followed by daily use of a medium-potency topical corticosteroid for 3 weeks (rank-down therapy); 49 patients were randomized (proactive therapy, n = 24; rank-down therapy, n = 25). During maintenance treatment, the relapse rate was 8.33% in the proactive therapy group and 20.0% in the rank-down therapy group (p = 0.0859). The mean (±standard deviation) itching score on a numerical rating scale in the rank-down therapy group increased significantly from 2.5 ± 1.9 to 3.6 ± 2.6 (p = 0.0438). Adverse events occurred in 2 patients receiving proactive therapy and 3 patients receiving rank-down therapy. Proactive therapy appears to be as safe as rank-down therapy and may be more effective for itch in pediatric AD in remission. MDPI 2022-10-31 /pmc/articles/PMC9658234/ /pubmed/36362704 http://dx.doi.org/10.3390/jcm11216477 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kamiya, Koji Saeki, Hidehisa Tokura, Yoshiki Yoshihara, Shigemi Sugai, Junichi Ohtsuki, Mamitaro Proactive versus Rank-Down Topical Corticosteroid Therapy for Maintenance of Remission in Pediatric Atopic Dermatitis: A Randomized, Open-Label, Active-Controlled, Parallel-Group Study (Anticipate Study) |
title | Proactive versus Rank-Down Topical Corticosteroid Therapy for Maintenance of Remission in Pediatric Atopic Dermatitis: A Randomized, Open-Label, Active-Controlled, Parallel-Group Study (Anticipate Study) |
title_full | Proactive versus Rank-Down Topical Corticosteroid Therapy for Maintenance of Remission in Pediatric Atopic Dermatitis: A Randomized, Open-Label, Active-Controlled, Parallel-Group Study (Anticipate Study) |
title_fullStr | Proactive versus Rank-Down Topical Corticosteroid Therapy for Maintenance of Remission in Pediatric Atopic Dermatitis: A Randomized, Open-Label, Active-Controlled, Parallel-Group Study (Anticipate Study) |
title_full_unstemmed | Proactive versus Rank-Down Topical Corticosteroid Therapy for Maintenance of Remission in Pediatric Atopic Dermatitis: A Randomized, Open-Label, Active-Controlled, Parallel-Group Study (Anticipate Study) |
title_short | Proactive versus Rank-Down Topical Corticosteroid Therapy for Maintenance of Remission in Pediatric Atopic Dermatitis: A Randomized, Open-Label, Active-Controlled, Parallel-Group Study (Anticipate Study) |
title_sort | proactive versus rank-down topical corticosteroid therapy for maintenance of remission in pediatric atopic dermatitis: a randomized, open-label, active-controlled, parallel-group study (anticipate study) |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658234/ https://www.ncbi.nlm.nih.gov/pubmed/36362704 http://dx.doi.org/10.3390/jcm11216477 |
work_keys_str_mv | AT kamiyakoji proactiveversusrankdowntopicalcorticosteroidtherapyformaintenanceofremissioninpediatricatopicdermatitisarandomizedopenlabelactivecontrolledparallelgroupstudyanticipatestudy AT saekihidehisa proactiveversusrankdowntopicalcorticosteroidtherapyformaintenanceofremissioninpediatricatopicdermatitisarandomizedopenlabelactivecontrolledparallelgroupstudyanticipatestudy AT tokurayoshiki proactiveversusrankdowntopicalcorticosteroidtherapyformaintenanceofremissioninpediatricatopicdermatitisarandomizedopenlabelactivecontrolledparallelgroupstudyanticipatestudy AT yoshiharashigemi proactiveversusrankdowntopicalcorticosteroidtherapyformaintenanceofremissioninpediatricatopicdermatitisarandomizedopenlabelactivecontrolledparallelgroupstudyanticipatestudy AT sugaijunichi proactiveversusrankdowntopicalcorticosteroidtherapyformaintenanceofremissioninpediatricatopicdermatitisarandomizedopenlabelactivecontrolledparallelgroupstudyanticipatestudy AT ohtsukimamitaro proactiveversusrankdowntopicalcorticosteroidtherapyformaintenanceofremissioninpediatricatopicdermatitisarandomizedopenlabelactivecontrolledparallelgroupstudyanticipatestudy |